DECOMPENSATED LIVER CIRRHOSIS
Clinical trials for DECOMPENSATED LIVER CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new DECOMPENSATED LIVER CIRRHOSIS trials appear
Sign up with your email to follow new studies for DECOMPENSATED LIVER CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cholesterol drug help slow liver failure?
Disease control Recruiting nowThis study tests whether adding a statin (atorvastatin) to a standard beta-blocker can help people with decompensated cirrhosis, a serious form of liver disease. About 50 participants will receive either the combination or a beta-blocker plus placebo and be followed for 12 months…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Phase: PHASE2 • Sponsor: CAMC Health System • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Engineered immune cells aim to calm liver damage in first human trial
Disease control Recruiting nowThis study tests a new treatment called RTX001 for people with severe liver cirrhosis that has caused complications. RTX001 uses the patient's own immune cells (macrophages) that are modified in a lab to reduce inflammation and scarring in the liver. The trial will enroll 30 adul…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Phase: PHASE1, PHASE2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Liver shunt study aims to refine who benefits most
Knowledge-focused Recruiting nowThis study follows 250 adults with decompensated liver cirrhosis who are receiving a TIPS procedure, a shunt that helps relieve pressure in the liver. Researchers will track survival, brain function, nutrition, and quality of life over one year. The goal is to learn which patient…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC